ACE and hepatocellular carcinoma: Various ACE inhibitors have been shown to suppress tumor growth and/or blood vessel formation in mouse models of squamous cell cancer [44], hepatocellular carcinoma [45], pancreatic cancer [46] and renal cell carcinoma [47].